Loading...

P04.06 PD-L1 Expression is Associated with Wild Type IDH, Immune Response and DNA Damage in Malignant Gliomas

BACKGROUND: Immune-checkpoint inhibition is a promising new approach in glioma therapy. Currently, this therapy is being evaluated for glioblastoma in different clinical trials. Since the molecular mechanism of PD-L1 regulation in gliomas is largely unknown, the present study was initiated.. METHODS...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Heiland, D. H., Haaker, J. G.
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5782582/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.084
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!